 |
|
|
|
|
|
 |
Learn about our UK operations.
|
|
|
|
|
|
|
|
|
|
|
|
 |
Explore opportunities in our entreprenuerial culture.
|
|
|
|
|
|
|
|
|
|
|
|
 |
Learn what's new for Genzyme in the UK.
|
|
|
|
|
|
|
|
|
|
|
|
 |
Find out what is new in our research and development.
|
|
|
|
|
|
|
|
Genzyme
New ‘Stem Cell Mobilisation’ Technology Accepted For Use by the Scottish Medicines Consortium
Genzyme UK today welcomes the decision by the Scottish Medicines Consortium (SMC) to accept Mozobil® (plerixafor) for use within NHS Scotland. Mozobil is a new ‘stem cell mobilisation’ therapy which is aimed at improving results for patients who are undergoing stem cell transplantation as part of their treatment for the blood cancers multiple myeloma and lymphoma. More>
|
UK Scientist Wins Prestigious International Grant to Support Innovative Research in Renal Diseases
A UK renal research unit is among the eight winners of the 2009 Genzyme Renal Innovations Programme (GRIP) awards. Established in 2001, the international GRIP awards aims to support the advancement of medical knowledge and practice in kidney diseases through innovative research in nephrology. More>
|
Andrew Lansley MP, Shadow Secretary of State for Health, sees cutting edge biotech science at Genzyme Europe Research in Cambridge
South Cambridgeshire MP and Shadow Secretary of State for Health Andrew Lansley CBE, welcomes Peter Harris to his new role as Genzyme Europe R+D site head today. More>
|
|
|
Genzyme UK Home
Genzyme Corporate Home
